Longitudinal characterisation of function and structure of Bietti crystalline dystrophy

report on a novel homozygous mutation in CYP4V2

Catherine M. Lockhart, Travis Smith, Paul Yang, Malini Naidu, Allan E. Rettie, Abhinav Nath, Richard Weleber, Edward J. Kelly

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND: Bietti crystalline dystrophy (BCD) is a rare inherited disorder characterised by fine crystalline deposits in the corneal limbus and retinal posterior pole. In 2004, mutations in the CYP4V2 gene were identified as the cause of BCD. Here, we describe the report of a homozygous point mutation in a patient with BCD and provide detailed characterisation of functional and structural changes over 20 years.

METHODS: At regular intervals, the patient underwent repeat ophthalmic evaluations. DNA was extracted from buccal swabs, amplified by standard PCR and analysed for homology to the CYP4V2 sequence. Homology modelling was conducted using Iterative Threading ASSEmbly Refinement and molecular dynamics simulations using GROningen MAchine for Chemical Simulations.

RESULTS: The proband, a 47-year-old woman of German ancestry was diagnosed with crystalline retinopathy at age 25. Over the next 20 years, visual acuity and function gradually declined with progression of retinal pigment epithelium and choroidal atrophy. When first tested at 39 years of age, the multifocal electroretinogram (ERG) was markedly abnormal, more so for the right eye, whereas the full-field ERG was more symmetrical and lagged other measures of visual function. Gene sequencing showed a single C>T point mutation in exon 9 encoding a R400C amino acid change. Computational modelling suggests the mutation impairs function due to loss of a hydrogen bonding interaction with the propionate side chains of the haeme prosthetic group.

CONCLUSION: This is the first report of a homozygous R400C mutation in CYP4V2 with protein modelling showing high likelihood of enzyme dysfunction. The comprehensive long-term clinical follow-up provides insight into disease progression and highlights possible anti-inflammatory modulation of disease severity.

Original languageEnglish (US)
Pages (from-to)187-194
Number of pages8
JournalThe British journal of ophthalmology
Volume102
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Point Mutation
Mutation
Limbus Corneae
Retinal Pigment Epithelium
Cheek
Propionates
Molecular Dynamics Simulation
Hydrogen Bonding
Heme
Genes
Visual Acuity
Atrophy
Disease Progression
Exons
Anti-Inflammatory Agents
Amino Acids
Polymerase Chain Reaction
DNA
Enzymes
Bietti Crystalline Dystrophy

Keywords

  • Bietti crystalline dystrophy
  • CYP4V2
  • macular edema
  • protein modeling

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Longitudinal characterisation of function and structure of Bietti crystalline dystrophy : report on a novel homozygous mutation in CYP4V2. / Lockhart, Catherine M.; Smith, Travis; Yang, Paul; Naidu, Malini; Rettie, Allan E.; Nath, Abhinav; Weleber, Richard; Kelly, Edward J.

In: The British journal of ophthalmology, Vol. 102, No. 2, 01.02.2018, p. 187-194.

Research output: Contribution to journalArticle

Lockhart, Catherine M. ; Smith, Travis ; Yang, Paul ; Naidu, Malini ; Rettie, Allan E. ; Nath, Abhinav ; Weleber, Richard ; Kelly, Edward J. / Longitudinal characterisation of function and structure of Bietti crystalline dystrophy : report on a novel homozygous mutation in CYP4V2. In: The British journal of ophthalmology. 2018 ; Vol. 102, No. 2. pp. 187-194.
@article{1347cea41ef84aa782ab0a027b2607df,
title = "Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2",
abstract = "BACKGROUND: Bietti crystalline dystrophy (BCD) is a rare inherited disorder characterised by fine crystalline deposits in the corneal limbus and retinal posterior pole. In 2004, mutations in the CYP4V2 gene were identified as the cause of BCD. Here, we describe the report of a homozygous point mutation in a patient with BCD and provide detailed characterisation of functional and structural changes over 20 years.METHODS: At regular intervals, the patient underwent repeat ophthalmic evaluations. DNA was extracted from buccal swabs, amplified by standard PCR and analysed for homology to the CYP4V2 sequence. Homology modelling was conducted using Iterative Threading ASSEmbly Refinement and molecular dynamics simulations using GROningen MAchine for Chemical Simulations.RESULTS: The proband, a 47-year-old woman of German ancestry was diagnosed with crystalline retinopathy at age 25. Over the next 20 years, visual acuity and function gradually declined with progression of retinal pigment epithelium and choroidal atrophy. When first tested at 39 years of age, the multifocal electroretinogram (ERG) was markedly abnormal, more so for the right eye, whereas the full-field ERG was more symmetrical and lagged other measures of visual function. Gene sequencing showed a single C>T point mutation in exon 9 encoding a R400C amino acid change. Computational modelling suggests the mutation impairs function due to loss of a hydrogen bonding interaction with the propionate side chains of the haeme prosthetic group.CONCLUSION: This is the first report of a homozygous R400C mutation in CYP4V2 with protein modelling showing high likelihood of enzyme dysfunction. The comprehensive long-term clinical follow-up provides insight into disease progression and highlights possible anti-inflammatory modulation of disease severity.",
keywords = "Bietti crystalline dystrophy, CYP4V2, macular edema, protein modeling",
author = "Lockhart, {Catherine M.} and Travis Smith and Paul Yang and Malini Naidu and Rettie, {Allan E.} and Abhinav Nath and Richard Weleber and Kelly, {Edward J.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1136/bjophthalmol-2016-309696",
language = "English (US)",
volume = "102",
pages = "187--194",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Longitudinal characterisation of function and structure of Bietti crystalline dystrophy

T2 - report on a novel homozygous mutation in CYP4V2

AU - Lockhart, Catherine M.

AU - Smith, Travis

AU - Yang, Paul

AU - Naidu, Malini

AU - Rettie, Allan E.

AU - Nath, Abhinav

AU - Weleber, Richard

AU - Kelly, Edward J.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - BACKGROUND: Bietti crystalline dystrophy (BCD) is a rare inherited disorder characterised by fine crystalline deposits in the corneal limbus and retinal posterior pole. In 2004, mutations in the CYP4V2 gene were identified as the cause of BCD. Here, we describe the report of a homozygous point mutation in a patient with BCD and provide detailed characterisation of functional and structural changes over 20 years.METHODS: At regular intervals, the patient underwent repeat ophthalmic evaluations. DNA was extracted from buccal swabs, amplified by standard PCR and analysed for homology to the CYP4V2 sequence. Homology modelling was conducted using Iterative Threading ASSEmbly Refinement and molecular dynamics simulations using GROningen MAchine for Chemical Simulations.RESULTS: The proband, a 47-year-old woman of German ancestry was diagnosed with crystalline retinopathy at age 25. Over the next 20 years, visual acuity and function gradually declined with progression of retinal pigment epithelium and choroidal atrophy. When first tested at 39 years of age, the multifocal electroretinogram (ERG) was markedly abnormal, more so for the right eye, whereas the full-field ERG was more symmetrical and lagged other measures of visual function. Gene sequencing showed a single C>T point mutation in exon 9 encoding a R400C amino acid change. Computational modelling suggests the mutation impairs function due to loss of a hydrogen bonding interaction with the propionate side chains of the haeme prosthetic group.CONCLUSION: This is the first report of a homozygous R400C mutation in CYP4V2 with protein modelling showing high likelihood of enzyme dysfunction. The comprehensive long-term clinical follow-up provides insight into disease progression and highlights possible anti-inflammatory modulation of disease severity.

AB - BACKGROUND: Bietti crystalline dystrophy (BCD) is a rare inherited disorder characterised by fine crystalline deposits in the corneal limbus and retinal posterior pole. In 2004, mutations in the CYP4V2 gene were identified as the cause of BCD. Here, we describe the report of a homozygous point mutation in a patient with BCD and provide detailed characterisation of functional and structural changes over 20 years.METHODS: At regular intervals, the patient underwent repeat ophthalmic evaluations. DNA was extracted from buccal swabs, amplified by standard PCR and analysed for homology to the CYP4V2 sequence. Homology modelling was conducted using Iterative Threading ASSEmbly Refinement and molecular dynamics simulations using GROningen MAchine for Chemical Simulations.RESULTS: The proband, a 47-year-old woman of German ancestry was diagnosed with crystalline retinopathy at age 25. Over the next 20 years, visual acuity and function gradually declined with progression of retinal pigment epithelium and choroidal atrophy. When first tested at 39 years of age, the multifocal electroretinogram (ERG) was markedly abnormal, more so for the right eye, whereas the full-field ERG was more symmetrical and lagged other measures of visual function. Gene sequencing showed a single C>T point mutation in exon 9 encoding a R400C amino acid change. Computational modelling suggests the mutation impairs function due to loss of a hydrogen bonding interaction with the propionate side chains of the haeme prosthetic group.CONCLUSION: This is the first report of a homozygous R400C mutation in CYP4V2 with protein modelling showing high likelihood of enzyme dysfunction. The comprehensive long-term clinical follow-up provides insight into disease progression and highlights possible anti-inflammatory modulation of disease severity.

KW - Bietti crystalline dystrophy

KW - CYP4V2

KW - macular edema

KW - protein modeling

UR - http://www.scopus.com/inward/record.url?scp=85042125895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042125895&partnerID=8YFLogxK

U2 - 10.1136/bjophthalmol-2016-309696

DO - 10.1136/bjophthalmol-2016-309696

M3 - Article

VL - 102

SP - 187

EP - 194

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 2

ER -